Related Experiment Videos
Eye tracking and schizophrenia: a selective review
D L Levy1, P S Holzman, S Matthysse
1McLean Hospital, Belmont, MA 02178.
Schizophrenia Bulletin
|January 1, 1994
Summary
Eye tracking dysfunction (ETD) is found in schizophrenia patients and relatives, suggesting it may indicate a schizophrenia genotype. Further research is needed to assess ETD
Area of Science:
- Neuroscience
- Psychiatry
- Genetics
Background:
- Eye tracking dysfunction (ETD) is a potential biomarker in schizophrenia.
- Replicated findings suggest ETD's relevance in schizophrenia patient populations and their families.
- Understanding ETD's role can inform genetic studies of schizophrenia.
Purpose of the Study:
- To review and critically assess the existing literature on eye tracking dysfunction (ETD) in schizophrenia.
- To examine the syndrome and familial specificity of ETD.
- To discuss quantitative methods for assessing eye tracking.
Main Methods:
- Literature review and critical assessment of studies on eye tracking dysfunction.
- Analysis of ETD findings in schizophrenia patients and their first-degree relatives.
- Discussion of quantitative eye tracking assessment techniques.
Main Results:
- Replicated findings of ETD in schizophrenia patients and their first-degree relatives.
- ETD shows potential as a marker for schizophrenia genotype studies.
- The literature supports ETD's relevance across defined phenotypes.
Conclusions:
- Eye tracking dysfunction (ETD) is a promising endophenotype for schizophrenia research.
- ETD may aid in identifying genetic factors associated with schizophrenia.
- Further investigation into quantitative eye tracking measures is warranted.